Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a25428d0b87ccf71

Jump to content

// Workers AI · dad joke modeIs 1-Keto-1,2,3,4-tetrahydrophenanthrene a phenom?

From Wikipedia, the free encyclopedia
(Redirected from C14H12O)
1-Keto-1,2,3,4-tetrahydrophenanthrene
Clinical data
Other namesTHP-1; 1,2,3,4-Tetrahydrophenanthren-1-one
Identifiers
  • 3,4-Dihydro-2H-phenanthren-1-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H12O
Molar mass196.249 g·mol−1
3D model (JSmol)
  • C1CC2=C(C=CC3=CC=CC=C23)C(=O)C1
  • InChI=1S/C14H12O/c15-14-7-3-6-12-11-5-2-1-4-10(11)8-9-13(12)14/h1-2,4-5,8-9H,3,6-7H2
  • Key:KBARGPSSEIXDQU-UHFFFAOYSA-N

1-Keto-1,2,3,4-tetrahydrophenanthrene (THP-1), or 1,2,3,4-tetrahydrophenanthren-1-one, is a synthetic steroid-like compound which was reported to be the first xenoestrogen.[1][2] It was first synthesized in 1933 by Cook et al. and was tested due to its similarity to the presumed chemical structure of estrone.[1][2] Upon reassessment many decades later, the compound was found to bind only weakly to the estrogen receptors, and, unexpectedly, did not actually have functional activity as an estrogen or antiestrogen in vitro or in vivo.[2] It did, however, show some mixed androgenic and antiandrogenic activity in vitro.[2]

See also

[edit]

References

[edit]
  1. 1 2 Virgil Craig Jordan (1986). Estrogen/antiestrogen Action and Breast Cancer Therapy. Univ of Wisconsin Press. pp. 20–. ISBN 978-0-299-10480-1.
  2. 1 2 3 4 Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP (2000). "Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays". Toxicol. Lett. 115 (3): 231–8. doi:10.1016/s0378-4274(00)00198-3. PMID 10814893.